Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 5, 2001

Primary Completion Date

July 31, 2004

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

estramustine phosphate sodium

DRUG

isotretinoin

DRUG

mitoxantrone hydrochloride

DRUG

paclitaxel

DRUG

vinorelbine ditartrate

Trial Locations (19)

10466

MBCCOP-Our Lady of Mercy Cancer Center, The Bronx

19111

Fox Chase Cancer Center, Philadelphia

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

30322

Emory University Hospital - Atlanta, Atlanta

55416

CCOP - Metro-Minnesota, Saint Louis Park

55905

Mayo Clinic Cancer Center, Rochester

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

58122

CCOP - Merit Care Hospital, Fargo

61801

CCOP - Carle Cancer Center, Urbana

80224

CCOP - Colorado Cancer Research Program, Incorporated, Denver

02111

Tufts - New England Medical Center, Boston

49007-3731

CCOP - Kalamazoo, Kalamazoo

07601

CCOP - Northern New Jersey, Hackensack

08903

Cancer Institute of New Jersey, New Brunswick

44106-5065

Ireland Cancer Center, Cleveland

43623-3456

CCOP - Toledo Community Hospital, Toledo

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

54307-3453

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

53226-3596

Medical College of Wisconsin Cancer Center, Milwaukee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00005847 - Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter